We offer a comprehensive range of products and services to support customers throughout the entire RNA medicine development process, from initial design to commercial manufacturing.
Chemoenzymatic ligation comes of age：A present-day solution for scalable manufacturing for siRNA and sgRNA drugs
May 18, 2026
In this webinar, our CTO, David Butler presented the latest advancements in Hongene's chemoenzymatic ligation platform for oligonucleotides synthesis and provided strategic insights that will help researchers and companies navigate drug development process using the ligation technology.
